Spero Therapeutics(DE:2HA)
€0.90-0.03 (-3.03%)
DE:2HA
Spero Therapeutics earnings date
€0.90
At close:-0.03 (-3.03%)
Spero Therapeutics (2HA) Q3 2018 Earnings Report
2 Followers
DE:2HA Q3 2018 EPS Results
- Actual EPS
- -EUR 0.54
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- -EUR 32.56
DE:2HA Q3 2018 Revenue Results
- Actual Revenue
- EUR 594.79K
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q3 2018
- Date
- 11/08/2018
- Time
- TBA
- Conference Call
- Thursday, November 8, 2018
DE:2HA Upcoming Earnings
Spero Therapeutics's next earnings date is estimated for April 1, 2027, based on past reporting schedules.
Q3 2018 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q3 2018 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2018 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:2HA Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Apr 01, 2027 | 2026 (Q4) | -0.17- | -0.12 | ― | ― |
| Nov 12, 2026 | 2026 (Q3) | -0.42-0.69 | -0.12 | -484.62% (-0.57) | |
| Aug 12, 2026 | 2026 (Q2) | ―-0.14 | -0.03 | -433.33% (-0.12) | |
| May 13, 2026 | 2026 (Q1) | ―-0.12 | -0.23 | 48.00% (+0.11) | |
| Mar 26, 2026 | 2025 (Q4) | -0.180.48 | -0.34 | 239.47% (+0.82) | |
| Nov 13, 2025 | 2025 (Q3) | -0.23-0.12 | -0.29 | 59.38% (+0.17) | |
| Aug 12, 2025 | 2025 (Q2) | -0.34-0.03 | -0.3 | 90.91% (+0.27) | |
| May 13, 2025 | 2025 (Q1) | -0.50-0.23 | -0.22 | -4.17% (-0.01) | |
| Mar 27, 2025 | 2024 (Q4) | -0.28-0.34 | 0.87 | -139.58% (-1.21) | |
| Nov 14, 2024 | 2024 (Q3) | -0.24-0.29 | -0.05 | -433.33% (-0.24) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
